 REDWOOD CITY, CA ACCESSWIRE December 23, 2020 Avinger, Inc. Nasdaq:AVGR, a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease PAD, today announced results of its annual meeting of stockholders the Annual Meeting, concluded on December 23, 2020. At the Annual Meeting, proposals were presented to elect one director to serve until the 2023 annual meeting, to ratify the appointment of the Companys public accountant for the year ended December 31, 2020, to approve an amendment to the Companys Amended and Restated Certificate of Incorporation to effect a reverse stock split, and to adjourn the Annual Meeting for the purpose of continuing to solicit votes with respect to the proposals presented. 